125 related articles for article (PubMed ID: 2263671)
21. Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex.
Ashby CR; Jiang LH; Kasser RJ; Wang RY
J Pharmacol Exp Ther; 1990 Jan; 252(1):171-8. PubMed ID: 2137174
[TBL] [Abstract][Full Text] [Related]
22. Do classical hallucinogens act as 5-HT2 agonists or antagonists?
Glennon RA
Neuropsychopharmacology; 1990; 3(5-6):509-17. PubMed ID: 2078284
[TBL] [Abstract][Full Text] [Related]
23. Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin.
Darmani NA; Martin BR; Glennon RA
J Pharmacol Exp Ther; 1992 Aug; 262(2):692-8. PubMed ID: 1501117
[TBL] [Abstract][Full Text] [Related]
24. 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavioral responses in neonatal rat pups.
Kirstein CL; Spear LP
Eur J Pharmacol; 1988 Jun; 150(3):339-45. PubMed ID: 2970973
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.
Darmani NA
Pharmacol Biochem Behav; 2001 Feb; 68(2):311-7. PubMed ID: 11267636
[TBL] [Abstract][Full Text] [Related]
26. Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI).
Pranzatelli MR
Neurosci Lett; 1990 Jul; 115(1):74-80. PubMed ID: 2216059
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors.
Darmani NA; Martin BR; Pandey U; Glennon RA
Pharmacol Biochem Behav; 1991 Feb; 38(2):353-7. PubMed ID: 1676173
[TBL] [Abstract][Full Text] [Related]
28. Withdrawal from chronic treatment with (+/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice.
Darmani NA; Martin BR; Glennon RA
Eur J Pharmacol; 1990 Sep; 186(1):115-8. PubMed ID: 2282932
[TBL] [Abstract][Full Text] [Related]
29. The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior.
Klint T; Dahlgren IL; Larsson K
Eur J Pharmacol; 1992 Mar; 212(2-3):241-6. PubMed ID: 1601066
[TBL] [Abstract][Full Text] [Related]
30. Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations.
Bagdy G; Kalogeras KT; Szemeredi K
Eur J Pharmacol; 1992 Dec; 229(1):9-14. PubMed ID: 1473565
[TBL] [Abstract][Full Text] [Related]
31. Potent agonist activity of DOB at 5-HT2 receptors in guinea pig trachea.
Heller WA; Baraban JM
Eur J Pharmacol; 1987 Jun; 138(1):115-7. PubMed ID: 3622603
[TBL] [Abstract][Full Text] [Related]
32. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
33. Neonatal organizational effects of the 5-HT2 and 5-HT1A subsystems on adult behavior in the rat.
González MI; Albonetti E; Siddiqui A; Farabollini F; Wilson CA
Pharmacol Biochem Behav; 1996 May; 54(1):195-203. PubMed ID: 8728558
[TBL] [Abstract][Full Text] [Related]
34. Differential ontogenesis of three DOI-induced behaviors in mice.
Darmani NA; Shaddy J; Gerdes CF
Physiol Behav; 1996 Dec; 60(6):1495-500. PubMed ID: 8946497
[TBL] [Abstract][Full Text] [Related]
35. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
36. 5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge.
McCall RB; Harris LT
Eur J Pharmacol; 1988 Jun; 151(1):113-6. PubMed ID: 3416918
[TBL] [Abstract][Full Text] [Related]
37. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors.
Ng NK; Lee HS; Wong PT
J Neurosci Res; 1999 Mar; 55(5):600-7. PubMed ID: 10082082
[TBL] [Abstract][Full Text] [Related]
38. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
[TBL] [Abstract][Full Text] [Related]
39. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.
Danzebrink RM; Gebhart GF
Brain Res; 1991 Jan; 538(1):64-75. PubMed ID: 2018933
[TBL] [Abstract][Full Text] [Related]
40. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
